Dosage of Tessalon Perles for Elderly Patients
The standard adult dosage of benzonatate (Tessalon Perles) applies to elderly patients without age-based dose reduction: 100-200 mg three times daily as needed for cough, with a maximum daily dose of 600 mg. 1
Standard Dosing Recommendations
The FDA-approved dosing for benzonatate is consistent across adult age groups 1:
- Usual dose: One capsule (100 mg, 150 mg, or 200 mg) three times daily as needed for cough
- Maximum daily dose: 600 mg in three divided doses
- Critical safety requirement: Capsules must be swallowed whole—never broken, chewed, dissolved, cut, or crushed 1
Age-Specific Considerations
No specific dose adjustment is required based on age alone for elderly patients. 1 This contrasts with many other medications where elderly patients require reduced dosing. The FDA labeling does not specify lower doses for geriatric populations, and available guidelines for antitussive use in elderly patients with lung cancer list benzonatate at the standard dose of 100-200 mg four times daily without age-based modifications 2.
Important Safety Considerations for Elderly Patients
While dose reduction is not required, elderly patients warrant heightened monitoring due to several factors 3:
- Polypharmacy risks: Elderly patients often take multiple medications, increasing the risk of drug interactions and medication errors
- Cognitive impairment: May affect ability to follow dosing instructions correctly, particularly the critical requirement to swallow capsules whole
- Renal function: Although benzonatate pharmacokinetics have not been extensively studied, elderly patients commonly have declining renal function that can affect drug clearance 4
Critical Safety Warnings
Benzonatate poses serious risks if not used correctly 1:
- Local anesthesia risk: If the capsule is chewed or dissolved in the mouth, it causes temporary oral/pharyngeal numbness and choking risk
- Overdose potential: Deaths have been reported in adults with overdose; serious adverse effects can occur within 15-20 minutes of ingestion 1, 5
- Intentional exposures: Among 106 intentional exposures in one poison center study, 22% experienced serious adverse effects including seizures, ECG changes, or CNS depression 5
Clinical Context
Benzonatate has limited evidence supporting its efficacy. A systematic review found substantial limitations in existing evidence regarding clinical effectiveness, with most studies having small sample sizes and high risk of bias 6. One study showed benzonatate combined with guaifenesin was more effective than either agent alone for viral URI-related cough 7, but benzonatate alone did not significantly suppress cough compared to placebo.
For elderly patients requiring cough suppression, consider the limited efficacy data and ensure patients can safely swallow capsules whole before prescribing. 2, 6 If swallowing difficulties exist, alternative antitussive agents should be considered.